A TLR2 and dectin-1 activator
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Zymosan A

Item No. 21175

Technical Information
CAS Number
58856-93-2
Formulation
A solid
Chloroform: 100 µg/mlDMSO: 200 µg/mlEthanol: 100 µg/ml
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Zymosan A is a glucan derived from the cell wall of S. cerevisiae that activates toll-like receptor 2 (TLR2) and a C-type lectin, dectin-1, on macrophages, monocytes, and dendritic cells to induce inflammatory signaling.1,2,3,4 It is commonly used to stimulate a sterile inflammatory response in mouse models of sepsis, shock, and peritonitis.5,6 In a mouse model of sepsis/shock, a lethal dose of zymosan A (500 mg/kg) in rats induced inflammation and shock leading to death.5 Zymosan A can also induce biosynthesis of eicosanoids.7

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Di Carlo, F.J., and Fiore, J.V. On the composition of zymosan. Science 127(3301), 756-757 (1958).

    2. Brown, G.D., and Gordon, S. Immune recognition: A new receptor for β-glucans. Nature 413(6851), 36-37 (2001).

    3. Pillemer, L., Blum, L., Lepow, I.H., et alThe properdin system and immunity. III. The zymosan assay of properdin. J. Exp. Med. 103(1), 1-13 (1956).

    4. Underhill, D.M., Ozinsky, A., Hajjar, A.M., et alThe Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401(6755), 811-815 (1999).

    5. Reynolds, F.D., Dauchy, R., Blask, D.E., et alThe pineal gland hormone melatonin improves survival in a rat model of sepsis/shock induced by zymosan A. Surgery 134(3), 474-479 (2003).

    6. Rao, T.S., Currie, J.L., Shaffer, A.F., et alIn Vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 269(3), 917-925 (1994).

    7. Humes, J.L., Sadowski, S., Galavage, M., et alEvidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. The Journal of Biological Chemisty 257(4), 1591-1594 (1982).